Company intelligence / Profile preview

Kan Biosys

Pune, Maharashtra, India
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

Kan Biosys is a leading Indian agri-biotech company that specializes in developing microbial solutions for sustainable agriculture and soil health. The company focuses on the research and manufacturing of bio-fertilizers, bio-pesticides, and soil conditioners that utilize beneficial microorganisms to enhance crop productivity. Their flagship product, Speed Kompost, provides an innovative solution for in-situ crop residue management, helping to mitigate the environmental impact of stubble burning. By integrating advanced fermentation technologies with ecological science, Kan Biosys offers biological alternatives that reduce the agricultural sector's reliance on chemical inputs. The company serves a global market, promoting regenerative farming practices and long-term soil sustainability. Their portfolio includes a wide range of microbial strains tailored for nitrogen fixation, phosphate solubilization, and pest control. Kan Biosys is recognized for its commitment to carbon sequestration and improving the carbon footprint of modern farming.

Therapeutic areas
OtherInfectious Diseases
Modalities
Microbial therapyBiologicLive biotherapeutic product therapy
Industry
Agriculture & AgTech

Beyond the preview

Go deeper on Kan Biosys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kan Biosys.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call